Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Ceftazidime 250mg powder for solution for injection vials |
| BNF code | 0501021H0AAADAD |
| Virtual Therapeutic Moiety | Ceftazidime |
| Date identifier became valid | 9 Jun 2023 |
| Previous product identifier | 323852008 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 17 May 2004 |
| Previous name | Ceftazidime 250mg injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 23 May 2008 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Ceftazidime pentahydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 387200005 |
| Strength value numerator | 250.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intravenous |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intramuscular-deep |
| Dose Form | |
| Formulation | Powder for solution for injection |
| Drug Route | |
| Route | Intramuscular |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Ceftazidime 250mg powder for solution for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.